https://www.zacks.com/stock/news/2219130/aflac-afl-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2219130
Jan 31, 2024 - The headline numbers for Aflac (AFL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:-3894482302702507161
0
https://www.zacks.com/stock/news/2218095/insurance-stocks-q4-earnings-due-on-jan-31-afl-met-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2218095
Jan 30, 2024 - Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
zc:7130511093988666830
0
https://www.zacks.com/stock/news/2217321/can-aflac-s-afl-q4-earnings-beat-on-strong-us-business?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217321
Jan 29, 2024 - Aflac's (AFL) Q4 results are likely to reflect a well-performing U.S. segment, strong net investment income, and a decline in benefits and claims.
zc:685131828756274620
0
https://www.zacks.com/stock/news/2216414/what-analyst-projections-for-key-metrics-reveal-about-aflac-afl-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2216414
Jan 26, 2024 - Beyond analysts' top -and-bottom-line estimates for Aflac (AFL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:987533578586790214
0
https://www.zacks.com/stock/news/2215226/will-the-specialty-unit-drive-renaissancere-rnr-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2215226
Jan 24, 2024 - RenaissanceRe's (RNR) Q4 results are expected to benefit from rate increases in the Property segment and a well-performing specialty business, partly offset by escalating claim expenses.
zc:4672052082042388014
0
https://www.zacks.com/stock/news/2215160/why-are-prudent-investors-favoring-aflac-afl-shares-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2215160
Jan 24, 2024 - Aflac's (AFL) product launches and cost-saving initiatives poise the company well for bottom-line growth.
zc:-1069776483342046012
0
https://www.zacks.com/stock/news/2206864/these-2-finance-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2206864
Jan 08, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
zc:4857242712026910647
0
https://www.zacks.com/stock/news/2206451/will-aflac-afl-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2206451
Jan 05, 2024 - Aflac (AFL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:-1079994162053346386
0
https://www.zacks.com/stock/news/2194850/reinsurance-group-rga-expands-capacity-with-launch-of-ruby-re?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2194850
Dec 07, 2023 - Reinsurance Group (RGA) gets access to alternative capital, expanding its capacity to underwrite risks.
zc:820209782348078766
0
https://www.zacks.com/stock/news/2194224/manulife-s-mfc-unit-inks-partnership-with-stepstone-scannell?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2194224
Dec 06, 2023 - Manulife's (MFC) Manulife Investment Management recapitalizes its portfolio with StepStone and Scannell.
zc:-921016687744050619
0